z-logo
open-access-imgOpen Access
A Novel Method for Removing Polyethyleneimine from Biopharmaceutical Samples: Improving Assay Sensitivity of Residual DNA Qpcr
Author(s) -
Shumin Zhang,
Matthew Roberts,
Marisa Jones,
Jacob Zeitler,
Greg W. Kilby,
Aston Liu,
John R. White
Publication year - 2020
Publication title -
biotechniques
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.617
H-Index - 131
eISSN - 1940-9818
pISSN - 0736-6205
DOI - 10.2144/btn-2020-0011
Subject(s) - dna , chromatography , genomic dna , biopharmaceutical , serial dilution , assay sensitivity , residual , microbiology and biotechnology , sodium dodecyl sulfate , alkaline lysis , polymerase chain reaction , chemistry , biology , plasmid , gene , biochemistry , medicine , dna vaccination , alternative medicine , pathology , algorithm , computer science
Polyethyleneimine (PEI) is a flocculent that is widely used in the downstream purification of monoclonal antibodies. It is an in-process residual that is carried through the drug purification process and strongly inhibits residual DNA quantitation by real-time quantitative PCR assay. Very high sample dilutions (e.g., 1:10,000) can overcome the interference of PEI, but at the cost of DNA assay sensitivity. Diluting samples poses a significant risk to the assay sensitivity needed to satisfy regulatory requirements on the quantitation of residual genomic DNA present per dose (i.e., 10 ng/dose). Removing PEI while retaining DNA, by the use of sodium dodecyl sulfate, heparin and/or sarkosyl can overcome the interference of PEI and allow a more accurate quantitation of residual DNA.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom